Most Closely Human Leukocyte Antigen (HLA)-Matched CMV-specific T Lymphocytes (Viralym-C)
Clinical trial NCT02313857 · COMPLETED
Trial details
- NCT number
- NCT02313857
- Sponsor
- AlloVir
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-01
- Primary completion
- 2017-05-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.